当前位置:首页 - 行情中心 - 立方制药(003020) - 财务分析

立方制药

(003020)

  

流通市值:24.92亿  总市值:34.52亿
流通股本:1.38亿   总股本:1.91亿

立方制药(003020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.16亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益192466.08万元,未分配利润94790.21万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产255482.40万元,负债63016.32万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,125,115,398.63769,332,113.02333,618,253.51,900,789,181.92
营业总成本1,000,958,904.88682,320,390.82307,762,871.441,682,608,293.1
营业利润131,563,699.4287,195,577.5429,015,119.09255,270,209.38
利润总额131,320,154.8386,943,206.6529,008,342.84257,416,741.72
净利润115,656,533.4875,992,607.4127,455,521.45233,882,579.75
其他综合收益----
综合收益总额115,656,533.4875,992,607.4127,455,521.45233,882,579.75
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,158,018,371.951,091,196,861.681,139,856,414.521,151,146,569.82
非流动资产合计1,396,805,593.891,392,707,684.251,354,516,110.481,332,533,005.35
资产总计2,554,823,965.842,483,904,545.932,494,372,5252,483,679,575.17
流动负债合计537,803,723.7538,581,011.91520,365,192.91542,729,282.88
非流动负债合计92,359,472.6666,378,914.9265,180,369.4367,452,277.62
负债合计630,163,196.36604,959,926.83585,545,562.34610,181,560.5
归属于母公司股东权益合计1,731,705,401.751,692,406,398.871,714,930,623.821,685,526,341.61
股东权益合计1,924,660,769.481,878,944,619.11,908,826,962.661,873,498,014.67
负债和股东权益合计2,554,823,965.842,483,904,545.932,494,372,5252,483,679,575.17
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,200,615,262.71772,837,780.92381,665,137.631,770,911,807.97
经营活动现金流出小计1,073,938,500.05695,118,489.57366,182,263.591,567,236,821.08
经营活动产生的现金流量净额126,676,762.6677,719,291.3515,482,874.04203,674,986.89
投资活动现金流入小计281,061,137.75178,245,654.551,459,925.7912,188,998.7
投资活动现金流出小计516,033,237.1389,690,178.32329,881,212.451,227,038,741.62
投资活动产生的现金流量净额-234,972,099.35-211,444,523.77-328,421,286.75-314,849,742.92
筹资活动现金流入小计29,117,727.92465,51463,100115,116,047.22
筹资活动现金流出小计103,752,671.06101,762,662.942,498,165.4378,490,735.02
筹资活动产生的现金流量净额-74,634,943.14-101,297,148.94-2,435,065.4336,625,312.2
汇率变动对现金及现金等价物的影响-8,840.681,385.721,614.0343,342.7
现金及现金等价物净增加额-182,939,120.51-235,020,995.64-315,371,864.11-74,506,101.13
期末现金及现金等价物余额319,783,092.31267,701,217.18187,350,348.71502,722,212.82
最新报告期:2024-10-31
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
招商证券焦玉鹏,许菲菲0.851.131.452024-10-31
TOP↑